Illumina launches genomics solutions for clinical research

Wednesday, October 7, 2015

Illumina has launched the new TruSeq library preparation kits and Infinium arrays that enable researchers to explore genetic variation on a more comprehensive scale. The new additions to the application-driven portfolio address a broad range of genetic studies from whole exome to population and disease specific genotyping, leveraging the Illumina portfolio of genomic analysis systems.

[Read More]

Illumina expands genomics analysis platform

Thursday, October 1, 2015

Illumina has announced several new additions to BaseSpace—a comprehensive cloud computing environment—with the launch of BaseSpace Professional and Enterprise Editions, fully integrated Laboratory Information Management System (LIMS) solutions and advanced infrastructure upgrades.

[Read More]

Illumina joins WIN Consortium

Wednesday, September 23, 2015

Illumina, a global provider of DNA sequencing and array-based technologies, has joined the Worldwide Innovative Networking (WIN) Consortium. Founded on the recognition that greater success can be achieved through collaboration than any organization can achieve alone, the WIN Consortium is a global network of academic, industry, insurance and nonprofit research organizations working to make personalized cancer care a reality for patients worldwide.

[Read More]

Burning Rock, Illumina collaborate

Wednesday, August 26, 2015

Burning Rock, a Guangzhou, China-based diagnostics company, has entered into an agreement to develop advanced clinical applications for molecular diagnostics in oncology based on Illumina’s next-generation sequencing (NGS) technology. The collaboration highlights the  importance of genomics to improve healthcare in China.

[Read More]

Illumina launches Illumina SeqLab

Friday, July 17, 2015

Illumina, a San Diego-based provider of sequencing and array-based technologies, has launched Illumina SeqLab, an integrated solution for customers with HiSeq X Systems to enable large-scale human whole-genome sequencing operations. Designed to increase laboratory efficiency for population-scale, human whole-genome sequencing (HWGS), this new offering provides a complete solution for Illumina customers who need streamlined workflows with integrated sample tracking and fast and accurate analysis solutions.

[Read More]

Illumina adds European headquarters in Cambridge, England

Friday, June 26, 2015

Illumina, a San Diego-based provider of sequencing and array-based technologies, has signed a 20-year lease for a 155,000 square foot new and innovative scientific research building in Cambridge, England. The project will provide Illumina a collaborative environment and access to the highly skilled workforce in the dynamic research cluster anchored by Cambridge University.

[Read More]

Denali Therapeutics launches to study neurodegenerative disease treatments

Friday, May 15, 2015

Denali Therapeutics, a new California-based biotechnology company focused on developing effective therapies for neurodegenerative diseases, has launched with an initial investment commitment of $217 million. Denali is based on the collaboration of world-class scientists, industry experts and investors. Recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines for Alzheimer’s disease, Parkinson’s disease, ALS and other neurodegenerative diseases.

[Read More]